Molycorp, Inc. is a rare earths producer. The Company operates in four business segments: Resources, Chemicals and Oxides, Magnetic Materials and Alloys and Rare Metals. The Resources segment includes its operations at the Mountain Pass facility. The Chemicals and Oxides segment includes the production of rare earths at Molycorp Silmet; production of separated heavy rare earth oxides and other engineered materials from its Molycorp Jiangyin facility, and production of rare earths, salts of rare earth elements (REEs), zirconium-based engineered materials and mixed rare earth/zirconium oxides from its Molycorp Zibo facility. The Magnetic Materials and Alloys segment includes the production of Neo Powders through its wholly owned manufacturing facilities. The Rare Metals segment produces, reclaims, refines and markets niche metals and their compounds.
Industry, Sector and Symbol:
- Sector: Materials
- Industry: Metals & Mining
- Sub-Industry: Diversified Metals & Mining
- Symbol: NYSE:MCP
- CUSIP: 60875310
- Web: www.molycorp.com/
Average Prices:- 200 Day Moving Avg: $1.00
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -0.87
- P/E Growth: 0
Dividend:
Profitability:- Net Margins: -293.82%
- Return on Equity: -250.99%
- Return on Assets: -54.96%
Frequently Asked Questions for Molycorp (NYSE:MCP)
What is Molycorp's stock symbol?
Molycorp trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCP."
How were Molycorp's earnings last quarter?
Molycorp Inc (NYSE:MCP) released its quarterly earnings results on Thursday, May, 7th. The company reported ($0.42) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $0.25. The business earned $106.42 million during the quarter, compared to analyst estimates of $184 million. Molycorp had a negative net margin of 293.82% and a negative return on equity of 250.99%. The firm's quarterly revenue was down 10.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.40) earnings per share. View Molycorp's Earnings History.
Where is Molycorp's stock going? Where will Molycorp's stock price be in 2017?
1 equities research analysts have issued 12 month price objectives for Molycorp's stock. Their forecasts range from $32.00 to $32.00. On average, they anticipate Molycorp's share price to reach $32.00 in the next twelve months. View Analyst Ratings for Molycorp.
Who are some of Molycorp's key competitors?
How do I buy Molycorp stock?
Shares of Molycorp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Molycorp's stock price today?
One share of Molycorp stock can currently be purchased for approximately $0.36.
MarketBeat Community Rating for Molycorp (NYSE MCP)MarketBeat's community ratings are surveys of what our community members think about Molycorp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Molycorp (NYSE:MCP) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Buy Rating |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $32.00 (8,821.10% upside) |
Analysts' Ratings History for Molycorp (NYSE:MCP)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 6/2/2017 | Ladenburg Thalmann Financial Services | Initiated Coverage | Buy | $32.00 | N/A |  |
(Data available from 7/26/2015 forward)
Earnings History for Molycorp (NYSE:MCP)Earnings History by Quarter for Molycorp (NYSE MCP)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/7/2015 | Q115 | ($0.17) | ($0.42) | $184.00 million | $106.42 million | View | N/A | |
| 3/16/2015 | Q4 | | ($0.39) | $123.80 million | $116.20 million | View | Listen | |
| 11/5/2014 | Q314 | ($0.27) | ($0.40) | $123.70 million | $123.00 million | View | Listen | |
| 8/6/2014 | Q214 | ($0.28) | ($0.29) | $130.97 million | $116.91 million | View | Listen | |
| 5/7/2014 | Q114 | ($0.21) | ($0.29) | $144.48 million | $118.50 million | View | Listen | |
| 3/3/2014 | Q4 | ($0.25) | ($0.28) | $148.30 million | $123.80 million | View | Listen | |
| 11/7/2013 | Q313 | ($0.29) | ($0.27) | $162.59 million | $149.10 million | View | Listen | |
| 8/8/2013 | Q2 2013 | ($0.23) | ($0.34) | $157.56 million | $136.90 million | View | Listen | |
| 5/9/2013 | Q1 2013 | ($0.29) | ($0.15) | $137.52 million | $146.40 million | View | Listen | |
| 3/14/2013 | Q4 2012 | ($0.30) | ($0.45) | $165.98 million | $134.30 million | View | Listen | |
| 11/8/2012 | Q312 | ($0.13) | ($0.05) | $247.60 million | $205.60 million | View | N/A | |
| 8/2/2012 | | $0.04 | ($0.03) | | | View | N/A | |
| 5/10/2012 | | $0.17 | $0.18 | | | View | N/A | |
| 2/23/2012 | | $0.40 | $0.41 | | | View | N/A | |
| 11/10/2011 | | $0.68 | $0.67 | | | View | N/A | |
| 8/11/2011 | | $0.39 | $0.52 | | | View | N/A | |
| 5/10/2011 | | $0.10 | $0.01 | | | View | N/A | |
| 3/9/2011 | | ($0.07) | ($0.03) | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Molycorp (NYSE:MCP)Current Year EPS Consensus Estimate: $-0.8500 EPS
Next Year EPS Consensus Estimate: $-0.4100 EPS
Dividend History for Molycorp (NYSE:MCP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Molycorp (NYSE:MCP)Insider Trades by Quarter for Molycorp (NYSE:MCP)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/15/2014 | Geoffrey Bedford | CEO | Buy | 50,000 | $2.76 | $138,000.00 | |
| 3/5/2014 | Y Metales S.A. Molibdenos | major shareholder | Buy | 14,650,000 | $5.00 | $73,250,000.00 | |
| 10/21/2013 | Geoffrey R Bedford | COO | Buy | 30,000 | $5.00 | $150,000.00 | |
| 8/20/2013 | Charles Henry | Director | Buy | 26,500 | $6.02 | $159,530.00 | |
| 1/30/2013 | Constantine Karayannopoulos | CEO | Buy | 16,667 | $6.00 | $100,002.00 | |
| 1/30/2013 | Y Metales S.A. Molibdenos | Major Shareholder | Buy | 15,000,000 | $6.00 | $90,000,000.00 | |
| 11/29/2012 | Brian T Dolan | Director | Buy | 4,413 | $8.69 | $38,348.97 | |
| 11/28/2012 | Y Metales S.A. Molibdenos | Major Shareholder | Buy | 50,000 | $8.18 | $409,000.00 | |
| 11/20/2012 | Charles R Henry | Director | Buy | 45,192 | $7.10 | $320,863.20 | |
| 11/19/2012 | John F Jr. Ashburn | EVP | Buy | 10,000 | $6.20 | $62,000.00 | |
| 11/19/2012 | Mark A Smith | CEO | Buy | 20,000 | $6.20 | $124,000.00 | |
| 8/22/2012 | Mark A Smith | CEO | Buy | 50,000 | $10.00 | $500,000.00 | |
| 8/22/2012 | Michael F Doolan | CFO | Buy | 25,000 | $10.00 | $250,000.00 | |
| 8/22/2012 | Russell David Ball | Director | Buy | 5,000 | $10.00 | $50,000.00 | |
| 8/22/2012 | Y Metales S.A. Molibdenos | Major Shareholder | Buy | 4,500,000 | $10.00 | $45,000,000.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Molycorp (NYSE:MCP)
Latest Headlines for Molycorp (NYSE:MCP)
| Source: |
|
Molycorp (MCP) Chart for Wednesday, July, 26, 2017
